News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Roche Battles Counterfeit Rituxin Vials In Germany     9/15/2014
FDA Approves Merck & Co., Inc.'s New-Kind Of Cancer Drug Keytruda     9/8/2014
AbbVie Hands Over $275 Million Upfront For Infinity Pharmaceuticals Inc.’s Blood Cancer Drug; Deal Could Be Worth $805 Million     9/5/2014
Tiny Redx Pharma Signs "Transformational" Cancer Deal With AstraZeneca PLC; Financial Terms Have Not Been Disclosed     9/4/2014
XBiotech USA, Inc. Halts Cancer Study On Positive Phase 3 Results     9/2/2014
OncoMed Pharmaceuticals, Inc. Says FDA Lifts Partial Hold On Cancer Drug Trials For Vantictumab     8/29/2014
Boston Startup OncoPep Secures $6.9 Million Series B Financing     8/28/2014
Illumina, Inc. Partners With AstraZeneca PLC, Johnson & Johnson To Create New Genetic Tests For Cancer     8/21/2014
Confirmed: Novartis AG To Invest In Gamida Cell Ltd., Could Buy Out Company In $635 Million Cancer Deal     8/19/2014
San Diego's Telik, Inc. Appoints New Board Members To Oversee Reinvigorated Cancer Pipeline     8/12/2014
Sanofi (France), Emcure Pharmaceuticals Limited Ink Marketing Pact For Cancer Drugs     8/6/2014
AstraZeneca PLC Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company, Merck & Co., Inc., And Roche     7/31/2014
Amgen Nervous As FDA Paves Way For Novartis AG To Copy Drug Neupogen     7/28/2014
Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial     7/24/2014
FDA Approves Eagle Pharmaceuticals' Ryanodex® For The Treatment Of Malignant Hyperthermia     7/23/2014

Featured Stories
Certain Form Of Baldness Linked To Prostate Cancer, National Cancer Institute Study     9/16/2014
UV Light Can Turn Gene Into Source Of Skin Cancers, Stanford University School of Medicine Study     9/10/2014
Prediabetes Increases The Risk Of Cancer By 15 Percent, The First People's Hospital Of Shunde Reveals     9/10/2014
Bras Cause Breast Cancer? Apparently Not, Fred Hutchinson Cancer Research Center Study     9/5/2014
Severing Nerves May Shrink Stomach Cancers, Columbia University Medical Center Study     8/21/2014
Children Face Higher Health Risk From Cell Phones, Environmental Health Trust Reveals     8/21/2014
Injected Bacteria Shrink Tumors In Rats, Dogs And Humans, Johns Hopkins University Study     8/20/2014
What Are The Health Benefits Of Bok Choy?     8/15/2014
Excess Body Weight Boosts Risk Of 10 Common Cancers, Lancet Study Reports     8/15/2014
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals     8/7/2014
Daily Dose Of Aspirin Can Cut Deaths From Three Kinds Of Cancer, Queen Mary University Of London Reveals     8/7/2014
A Reason Brain Tumors Are More Common In Men, Washington University School of Medicine Study     8/5/2014
Eating Resistant Starch May Help Reduce Red Meat Cancer Risk, Flinders University Study     8/5/2014
FDA Will Regulate Thousands Of Cancer, Genetic, And Other Diagnostic     8/5/2014
Military Strategies Being Used In The War Against Cancer     8/4/2014

More News
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Completion Of Patient Enrollment In The Phase 3 AFFINITY Trial Of Custirsen In Combination With Cabazitaxel/Prednisone As Second-Line Chemotherapy In Men With Metastatic Castrate-Resistant Prostate Cancer     9/16/2014
EnGeneIC Pty Ltd Named A Recipient Of The Cancer Institute NSW Premier's Award For Excellence In Translational Cancer Research     9/16/2014
Boston University School of Medicine Release: Study Finds High Protein Diets Lead To Lower Blood Pressure     9/15/2014
NantBioscience And University of Colorado To Collaborate On Development Of Novel Protein Cancer Fighting Drugs     9/15/2014
RestorGenex To Present At The American Association for Cancer Research Conference On Targeting The PI3K-MTOR Network In Cancer     9/15/2014
G1 Therapeutics Initiates Phase 1 Clinical Trial Of G1T28-1     9/11/2014
Elekta Knowledge Management harnesses Cancer Data Through Advanced Analytics     9/11/2014
Blueprint Medicines Discovers Novel Cancer Drug Targets     9/10/2014
Galena Biopharma  (GALE) Doses First Patient In GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial     9/9/2014
Champions Oncology, Inc. (CSBR) To Announce First Quarter Financial Results On Thursday, September 11     9/9/2014
Karmanos Cancer Institute's 21st Annual Partners Night Sept. 20 Honors Mary Kay And Keith Crain; Raises Funds For Cancer Research     9/9/2014
VG Life Sciences, Inc. (VGLS) Progress Update Phase I Cancer Study     9/4/2014
Rexahn Pharmaceuticals, Inc. (RNN) Receives A Notice Of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted Cancer Drug Delivery Platform     9/3/2014
BeiGene Co.,Ltd Enrolls First Patient In Phase 1 Study Of BGB-3111     8/26/2014
Glenmark Pharmaceuticals Enters Oncology With The Discovery And Initiation Of IND Enabling Studies Of An Innovative Bispecific Antibody     8/20/2014